Oncotelic Therapeutics, Inc. Convertible Notes Payable, Current
Oncotelic Therapeutics, Inc. (OTLC) had Convertible Notes Payable, Current of $37.03 thousand as of 2023-06-30, per its 10-Q filed 2023-08-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2024-04-12
- 2023-06-30: Convertible Notes Payable, Current $37.03K.
- 2023-03-31: Convertible Notes Payable, Current $349.36K.
- 2022-12-31: Convertible Notes Payable, Current $339.69K.
- 2022-09-30: Convertible Notes Payable, Current $291.75K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2023-06-30 | $37.03K 10-Q · filed 2023-08-18 | |
| 2023-03-31 | $349.36K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $339.69K 10-K · filed 2024-04-12 | |
| 2022-09-30 | $291.75K 10-Q · filed 2022-11-18 | |
| 2021-12-31 | $1.25M 10-K/A · filed 2023-04-20 | $2.35M 10-K · filed 2022-04-15 |
| 2021-09-30 | $2.07M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $1.80M 10-Q · filed 2021-08-20 | |
| 2021-03-31 | $1.52M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $943.59K 10-K · filed 2022-04-15 | |
| 2019-12-31 | $160.92K 10-K · filed 2020-05-14 |